Viewing Study NCT00320151



Ignite Creation Date: 2024-05-05 @ 4:50 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00320151
Status: COMPLETED
Last Update Posted: 2017-05-24
First Post: 2006-04-27

Brief Title: Collection of Blood for Gene Expression Study in Individuals With Chronic Lung Diseases
Sponsor: Weill Medical College of Cornell University
Organization: Weill Medical College of Cornell University

Study Overview

Official Title: Collection of Blood for Gene Expression Study in Individuals With Chronic Lung Diseases
Status: COMPLETED
Status Verified Date: 2017-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This protocol is designed to gather a small amount of blood from patients seen in the New York Presbyterian Hospital-Weill Cornell Medical Center Pulmonary Critical Care unit and 5 West floor Pulmonary Floor for clinical care associated with chronic lung disease This protocol will also survey medical records of patients with chronic lung disease in order to study the clinical characteristics of these individuals Investigators aim to understand the genetics of chronic lung diseases and will use the serum and DNA from this blood to perform various genotyping studies such as such as genomicgene expression studies of individuals with chronic lung diseases
Detailed Description: This protocol is designed to gather a small amount of blood from patients seen in the New York Presbyterian Hospital-Weill Cornell Medical Center Pulmonary Critical Care unit and 5 West floor Pulmonary Floor for clinical care associated with chronic lung disease This protocol will also survey medical records of patients with chronic lung disease in order to study the clinical characteristics of these individuals Investigators aim to understand the genetics of chronic lung diseases and will use the serum and DNA from this blood to perform various genotyping studies such as such as genomicgene expression studies of individuals with chronic lung diseases

General admission criteria for this project will require at least one of the following 1 symptoms consistent with pulmonary disease 2 chest X-ray consistent with lung disease 3 pulmonary function tests consistent with lung disease 4 lung biopsy consistent with lung disease 5 family history of lung disease and 6 patients with diseases of organs with known association with lung disease

The following studies will be conducted on blood specimens genomic DNA will be extracted promoter sequences for antioxidant-related genes will be obtained by PCR and sequenced The goal is to find single nucleotide polymorphisms SNP to see if they correlate with lung disease DNA samples and blood specimens will be coded Samples could potentially be traced back to the patient However every effort will be made to keep the patients identity confidential per HIPAA regulations

The study does not aim to create a blood bank Rather the blood samples will be used for DNA extraction only Serum will be stored for future studies to look at levels of proteins

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None